Isoflavones
"Isoflavones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position.
Descriptor ID |
D007529
|
MeSH Number(s) |
D03.383.663.283.266.450.400 D03.438.150.266.450.400
|
Concept/Terms |
Isoflavones- Isoflavones
- Isoflavone Derivatives
- Derivatives, Isoflavone
Homoisoflavones- Homoisoflavones
- 3-Benzylchroman-4-Ones
- 3 Benzylchroman 4 Ones
- 3-Benzylidene-4-Chromanones
- 3 Benzylidene 4 Chromanones
|
Below are MeSH descriptors whose meaning is more general than "Isoflavones".
Below are MeSH descriptors whose meaning is more specific than "Isoflavones".
This graph shows the total number of publications written about "Isoflavones" by people in this website by year, and whether "Isoflavones" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 2 | 0 | 2 | 2005 | 0 | 1 | 1 | 2006 | 1 | 0 | 1 | 2009 | 2 | 0 | 2 | 2010 | 1 | 0 | 1 | 2013 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Isoflavones" by people in Profiles.
-
Amato P, Young RL, Steinberg FM, Murray MJ, Lewis RD, Cramer MA, Barnes S, Ellis KJ, Shypailo RJ, Fraley JK, Konzelmann KL, Fischer JG, LaSalle C, Smith EO, Wong WW. Effect of soy isoflavone supplementation on menopausal quality of life. Menopause. 2013 Apr; 20(4):443-7.
-
Steinberg FM, Murray MJ, Lewis RD, Cramer MA, Amato P, Young RL, Barnes S, Konzelmann KL, Fischer JG, Ellis KJ, Shypailo RJ, Fraley JK, Smith EO, Wong WW. Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women. Am J Clin Nutr. 2011 Feb; 93(2):356-67.
-
Wong WW, Lewis RD, Steinberg FM, Murray MJ, Cramer MA, Amato P, Young RL, Barnes S, Ellis KJ, Shypailo RJ, Fraley JK, Konzelmann KL, Fischer JG, Smith EO. Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial. Am J Clin Nutr. 2009 Nov; 90(5):1433-9.
-
Maskarinec G, Verheus M, Steinberg FM, Amato P, Cramer MK, Lewis RD, Murray MJ, Young RL, Wong WW. Various doses of soy isoflavones do not modify mammographic density in postmenopausal women. J Nutr. 2009 May; 139(5):981-6.
-
Wang SW, Chen J, Jia X, Tam VH, Hu M. Disposition of flavonoids via enteric recycling: structural effects and lack of correlations between in vitro and in situ metabolic properties. Drug Metab Dispos. 2006 Nov; 34(11):1837-48.
-
Chen J, Wang S, Jia X, Bajimaya S, Lin H, Tam VH, Hu M. Disposition of flavonoids via recycling: comparison of intestinal versus hepatic disposition. Drug Metab Dispos. 2005 Dec; 33(12):1777-84.
-
Murray MJ, Meyer WR, Lessey BA, Oi RH, DeWire RE, Fritz MA. Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia in postmenopausal women: a pilot trial. Menopause. 2003 Sep-Oct; 10(5):456-64.
-
Steinberg FM, Guthrie NL, Villablanca AC, Kumar K, Murray MJ. Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am J Clin Nutr. 2003 Jul; 78(1):123-30.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|